Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BACMUNE (MV130) for Prevention of COVID-19 in Healthcare Personnel
NCT04452643Phase 3Withdrawn
- Sponsor
- Inmunotek
- Start
- Oct 2020
- Primary completion
- Dec 2021
- Modality
- Microbiome Therapeutics, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of MV130 in coronavirus disease 2019 (COVID-19), sponsored by Inmunotek. Planned start Oct 2020; status: withdrawn.
02
Drugs
MV130
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04452643.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04452643.